Pathology Studied Is Schizophrenia clinical trials

Explore recruiting pathology studied is schizophrenia clinical trials.

Also recruiting in Europe

Pathology Studied Is Schizophrenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using [18F]DPA-714

France

Phase II and Phase III (Integrated) EU CTIS Study details

Pathology Studied Is Schizophrenia trials by city

Pathology Studied Is Schizophrenia in Toronto Pathology Studied Is Schizophrenia in Vancouver Pathology Studied Is Schizophrenia in Montreal Pathology Studied Is Schizophrenia in Calgary Pathology Studied Is Schizophrenia in Edmonton Pathology Studied Is Schizophrenia in Ottawa Pathology Studied Is Schizophrenia in Winnipeg Pathology Studied Is Schizophrenia in Quebec City Pathology Studied Is Schizophrenia in Hamilton Pathology Studied Is Schizophrenia in Kitchener Pathology Studied Is Schizophrenia in London Pathology Studied Is Schizophrenia in Halifax Pathology Studied Is Schizophrenia in New York Pathology Studied Is Schizophrenia in Los Angeles Pathology Studied Is Schizophrenia in Chicago Pathology Studied Is Schizophrenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease